ALVNF yields 35.71% · PFE yields 6.13%● Live data
📍 ALVNF pulled ahead of the other in Year 1
Combined, ALVNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALVNF + PFE for your $10,000?
Alviva Holdings Limited provides information and communication technology (ICT) products and services in South Africa, rest of Africa, and internationally. It operates through three segments: ICT Distribution, Services and Solutions, and Financial Services. The ICT Distribution segment imports, assembles, distributes, and sells hardware and software products in sub-Saharan African markets through reseller channels and retail chains. The Services and Solutions segment provides systems integration and ICT solutions, including cybersecurity, application development, and artificial intelligence, as well as undertakes projects in the renewable energy. The Financial Services segment offers finance solutions to business entities in the SMME and commercial sectors. The company was formerly known as Pinnacle Holdings Limited and changed its name to Alviva Holdings Limited in March 2017. Alviva Holdings Limited was incorporated in 1986 and is based in Midrand, South Africa.
Full ALVNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.